WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr | ₹3.59 Cr | ₹2.88 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹3.95 Cr |
Mar2023 | ₹3.44 Cr |
Mar2022 | ₹0.21 Cr |
Mar2021 | ₹3.59 Cr |
Mar2020 | ₹2.88 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3.95 Cr | 14.84 | |
Mar2023 | ₹3.44 Cr | 1,513.62 | |
Mar2022 | ₹0.21 Cr | -94.06 | |
Mar2021 | ₹3.59 Cr | 24.61 | |
Mar2020 | ₹2.88 Cr | - |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,874.3 Cr | -12.4% | -3.5% | 67% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,394.0 Cr | -6.7% | 2.6% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹142,920.0 Cr | -6.6% | -3.7% | 43.8% | Stock Analytics | |
CIPLA | ₹114,383.0 Cr | -5.3% | -2.9% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,817.0 Cr | -3.8% | 1.8% | 25.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹91,385.4 Cr | -4.9% | -3.3% | -10.2% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -12.4% |
-3.5% |
67% |
SENSEX | -3.6% |
-0.7% |
-0.5% |
You may also like the below Video Courses